5-MethoxyisatinCAS# 39755-95-8 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 39755-95-8 | SDF | Download SDF |
| PubChem ID | 38333 | Appearance | Powder |
| Formula | C9H7NO3 | M.Wt | 177.16 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5-methoxy-1H-indole-2,3-dione | ||
| SMILES | COC1=CC2=C(C=C1)NC(=O)C2=O | ||
| Standard InChIKey | DMHGXMPXHPOXBF-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C9H7NO3/c1-13-5-2-3-7-6(4-5)8(11)9(12)10-7/h2-4H,1H3,(H,10,11,12) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
5-Methoxyisatin Dilution Calculator
5-Methoxyisatin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.6446 mL | 28.2231 mL | 56.4462 mL | 112.8923 mL | 141.1154 mL |
| 5 mM | 1.1289 mL | 5.6446 mL | 11.2892 mL | 22.5785 mL | 28.2231 mL |
| 10 mM | 0.5645 mL | 2.8223 mL | 5.6446 mL | 11.2892 mL | 14.1115 mL |
| 50 mM | 0.1129 mL | 0.5645 mL | 1.1289 mL | 2.2578 mL | 2.8223 mL |
| 100 mM | 0.0564 mL | 0.2822 mL | 0.5645 mL | 1.1289 mL | 1.4112 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Coumarin 7
Catalog No.:BCC8920
CAS No.:27425-55-4
- Picroside I
Catalog No.:BCN6322
CAS No.:27409-30-9
- threo-Guaiacylglycerol
Catalog No.:BCN5161
CAS No.:27391-16-8
- 4'-Hydroxy-7-methoxyflavan
Catalog No.:BCN3497
CAS No.:27348-54-5
- VX-765
Catalog No.:BCC3648
CAS No.:273404-37-8
- Precyasterone
Catalog No.:BCN2754
CAS No.:27335-85-9
- 5-Formyl-2-furylboronic acid
Catalog No.:BCC8748
CAS No.:27329-70-0
- Tirapazamine
Catalog No.:BCC5184
CAS No.:27314-97-2
- ICI 63197
Catalog No.:BCC7188
CAS No.:27277-00-5
- Phyllostine
Catalog No.:BCN4773
CAS No.:27270-89-9
- Levobupivacaine HCl
Catalog No.:BCC4675
CAS No.:27262-48-2
- N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide
Catalog No.:BCC9051
CAS No.:27262-40-4
- Xanthohumol D
Catalog No.:BCN5162
CAS No.:274675-25-1
- Neocryptotanshinone II
Catalog No.:BCN3138
CAS No.:27468-20-8
- Ticagrelor
Catalog No.:BCC4975
CAS No.:274693-27-5
- LE 300
Catalog No.:BCC7148
CAS No.:274694-98-3
- 7-Acetoxy-4-methylcoumarin
Catalog No.:BCC8775
CAS No.:2747-05-9
- H-Leu-OtBu.HCl
Catalog No.:BCC2974
CAS No.:2748-02-9
- O-Benzyldauricine
Catalog No.:BCC8222
CAS No.:2748-99-4
- Cyclo(D-Val-L-Pro)
Catalog No.:BCN4015
CAS No.:27483-18-7
- trans-4-Aminocyclohexanol
Catalog No.:BCC9181
CAS No.:27489-62-9
- L-Ala-ol
Catalog No.:BCC2590
CAS No.:2749-11-3
- 2-O-Acetyltutin
Catalog No.:BCN5163
CAS No.:2749-28-2
- Vildagliptin (LAF-237)
Catalog No.:BCC2112
CAS No.:274901-16-5
Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone: A water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity.[Pubmed:28801274]
Eur J Pharm Sci. 2017 Nov 15;109:381-388.
Targeting protein aggregation for the therapy of neurodegenerative diseases remains elusive for medicinal chemists, despite a number of small molecules known to interfere in amyloidogenesis, particularly of amyloid beta (Abeta) protein. Starting from previous findings in the antiaggregating activity of a class of indolin-2-ones inhibiting Abeta fibrillization, 5-Methoxyisatin 3-(4-isopropylphenyl)hydrazone 1 was identified as a multitarget inhibitor of Abeta aggregation and cholinesterases with IC50s in the low muM range. With the aim of increasing aqueous solubility, a Mannich-base functionalization led to the synthesis of N-methylpiperazine derivative 2. At acidic pH, an outstanding solubility increase of 2 over the parent compound 1 was proved through a turbidimetric method. HPLC analysis revealed an improved stability of the Mannich base 2 at pH2 along with a rapid release of 1 in human serum as well as an outstanding hydrolytic stability of the parent hydrazone. Coincubation of Abeta1-42 with 2 resulted in the accumulation of low MW oligomers, as detected with PICUP assay. Cell assays on SH-SY5Y cells revealed that 2 exerts strong cytoprotective effects in both cell viability and radical quenching assays, mainly related to its active metabolite 1. These findings show that 2 drives the formation of non-toxic, off-pathway Abeta oligomers unable to trigger the amyloid cascade and toxicity.
